FCRL3 anticorps (AA 122-222) (Biotin)

N° du produit ABIN7152659

Détail du produit anti-FCRL3 anticorps (Biotin)

Antigène: FCRL3 (Fc Receptor-Like 3 (FCRL3))

Épitope: AA 122-222

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FCRL3 est conjugé à/à la Biotin

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Fc receptor-like protein 3 protein (122-222AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur FCRL3

Antigène: FCRL3 (Fc Receptor-Like 3 (FCRL3))

Autre désignation: FCRL3 (FCRL3 Produits)

Synonymes: anticorps CD307c, anticorps FCRH3, anticorps IFGP3, anticorps IRTA3, anticorps SPAP2, anticorps fcrh3, anticorps ifgp3, anticorps irta3, anticorps spap2, anticorps xfl1.2, anticorps Fc receptor like 3, anticorps Fc receptor-like 3 L homeolog, anticorps Fc receptor-like 3, anticorps Fc receptor-like 3 S homeolog, anticorps FCRL3, anticorps fcrl3.L, anticorps fcrl3, anticorps fcrl3.S

Sujet:

Background: Promotes TLR9-induced B-cell proliferation, activation and survival but inhibits antibody production and suppresses plasma cell differentiation. Enhances activation of NF-kappa-B and MAPK signaling pathways in TLR9 stimulated B-cells (PubMed:23857366). Has inhibitory potentional on B-cell receptor (BCR)-mediated signaling, possibly through association with SH2 domain-containing phosphatases. Inhibits cell tyrosine phosphorylation, calcium mobilization and activation-induced cell death induced through BCR signaling (PubMed:19843936). Regulatory T-cells expressing FCRL3 exhibit a memory phenotype, are relatively nonresponsive to antigenic stimulation in presence of IL2 and have reduced capacity to suppress the proliferation of effector T-cells (PubMed:20190142, PubMed:19494275).

Aliases: CD307c antibody, Fc receptor homolog 3 antibody, Fc receptor-like protein 3 antibody, FcR-like protein 3 antibody, FcRH3 antibody, FcRL3 antibody, FCRL3_HUMAN antibody, hIFGP3 antibody, IFGP family protein 3 antibody, IFGP3 antibody, Immune receptor translocation-associated protein 3 antibody, Immunoglobulin superfamily receptor translocation associated protein 3 antibody, IRTA3 antibody, SH2 domain-containing phosphatase anchor protein 2 antibody, SPAP2 antibody

UniProt: Q96P31